Showing
1 - 4
results of
4
for search '
Peckham AM
'
Skip to content
Home
High Impact Articles
Search Options
UiTM Open Access
Search by UiTM Scopus
Advanced Search
Search by Category
Discovery Service
Sources
Jawi Collection
UiTM Journals
List UiTM Journal in IR
Statistic
About
Open Access
Creative Commons Licenses
COKI | Malaysia Open Access
Report Technical
User Guide
Contact Us
Search Tips
FAQs
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Author
Peckham AM
Showing
1 - 4
results of
4
for search '
Peckham AM
'
, query time: 0.04s
Refine Results
Sort
Relevance
Date Descending
Date Ascending
Call Number
Author
Title
1
Gabapentin use, abuse, and the US opioid epidemic: the case for reclassification as a controlled substance and the need for pharmacovigilance
by
Peckham
AM
,
Ananickal MJ
,
Sclar DA
Published 2018-08-01
Get full text
Article
2
Prevalence of depression and receipt of antidepressant pharmacotherapy among patients with Parkinson’s disease: a national assessment of US office-based physician visits
by
Early NK
,
Peckham
AM
,
Fairman KA
,
Sclar DA
Published 2017-11-01
Get full text
Article
3
Characterization of hospitalized patients who received naloxone while receiving opioids with or without gabapentinoids
by
Desai, P.H
,
Evoy, K.E
,
Peckham
,
A.M
,
Shah, K.J
,
Taylor, O.
Published 2021
Call Number:
Loading...
Located:
Loading...
View Fulltext in Publisher
Article
4
Leveraging pharmacists to maintain and extend buprenorphine supply for opioid use disorder amid COVID-19 pandemic
by
Ball, J.
,
Colvard, M.D
,
Dadiomov, D.
,
Hill, L.G
,
Nichols, S.D
,
Peckham
,
A.M
,
Tallian, K.
,
Tran, T.H
,
Ventricelli, D.J
Published 2021
Call Number:
Loading...
Located:
Loading...
View Fulltext in Publisher
Article
Search Tools:
Get RSS Feed
—
Email this Search
Related Subjects
Article
Buprenorphine
COVID-19
Gabapentin
Gabapentinoids
Health Services Accessibility
Humans
Naloxone
Narcotic Antagonists
Opiate Substitution Treatment
Opioid-Related Disorders
Opioids
Oversedation
Pandemics
Pharmacists
Pregabalin
Respiratory depression
SARS-CoV-2
United States
buprenorphine
clinical pharmacist
community care
coronavirus disease 2019
evidence based medicine
general condition deterioration
health care access
health care delivery
hospital patient
hospitalization
human
Loading...